These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 23336054

  • 1. Exploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: implications for cross-species comparisons.
    van den Buuse M.
    ACS Chem Neurosci; 2013 Jan 16; 4(1):149-60. PubMed ID: 23336054
    [Abstract] [Full Text] [Related]

  • 2. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
    Conti LH.
    Neuropharmacology; 2012 Jan 16; 62(1):256-63. PubMed ID: 21835187
    [Abstract] [Full Text] [Related]

  • 3. Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background.
    van den Buuse M, Martin S, Holgate J, Matthaei K, Hendry I.
    Psychopharmacology (Berl); 2007 Dec 16; 195(2):273-83. PubMed ID: 17684732
    [Abstract] [Full Text] [Related]

  • 4. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
    Gogos A, Bogeski M, van den Buuse M.
    Behav Pharmacol; 2008 Sep 16; 19(5-6):548-61. PubMed ID: 18690109
    [Abstract] [Full Text] [Related]

  • 5. Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation.
    Stancampiano R, Frau R, Bini V, Collu M, Carta M, Fadda F, Bortolato M.
    Eur Neuropsychopharmacol; 2013 Oct 16; 23(10):1329-35. PubMed ID: 23141373
    [Abstract] [Full Text] [Related]

  • 6. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A, Kwek P, Chavez C, van den Buuse M.
    J Pharmacol Exp Ther; 2010 Apr 16; 333(1):218-27. PubMed ID: 20042529
    [Abstract] [Full Text] [Related]

  • 7. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

  • 8. 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation.
    Gogos A, Kusljic S, van den Buuse M.
    Pharmacol Biochem Behav; 2005 Jul 11; 81(3):664-72. PubMed ID: 15955549
    [Abstract] [Full Text] [Related]

  • 9. The importance of baseline in identifying 8-OH-DPAT-induced effects on prepulse inhibition in rats.
    Gogos A, van den Buuse M.
    Br J Pharmacol; 2007 Mar 11; 150(6):750-7. PubMed ID: 17279088
    [Abstract] [Full Text] [Related]

  • 10. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition.
    Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA.
    Neuropsychopharmacology; 2000 Jun 11; 22(6):650-9. PubMed ID: 10788764
    [Abstract] [Full Text] [Related]

  • 11. 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action.
    Sipes TA, Geyer MA.
    Psychopharmacology (Berl); 1995 Jan 11; 117(1):41-8. PubMed ID: 7724701
    [Abstract] [Full Text] [Related]

  • 12. Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice.
    Marques AM, Macena MV, Cardoso AR, Hammes CSO, Pinheiro FML, Castro NG, Neves GA.
    Psychopharmacology (Berl); 2020 Jun 11; 237(6):1643-1655. PubMed ID: 32095916
    [Abstract] [Full Text] [Related]

  • 13. The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice.
    Sakaue M, Ago Y, Baba A, Matsuda T.
    Psychopharmacology (Berl); 2003 Oct 11; 170(1):73-9. PubMed ID: 12768276
    [Abstract] [Full Text] [Related]

  • 14. Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice.
    Gogos A, Martin S, Jones ME, van den Buuse M.
    Psychopharmacology (Berl); 2006 Sep 11; 188(1):100-10. PubMed ID: 16896955
    [Abstract] [Full Text] [Related]

  • 15. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice.
    Dulawa SC, Geyer MA.
    Neuropharmacology; 2000 Aug 23; 39(11):2170-9. PubMed ID: 10963760
    [Abstract] [Full Text] [Related]

  • 16. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801.
    Bubeníková-Valesová V, Votava M, Pálenícek T, Horácek J.
    Neuropharmacology; 2007 Mar 23; 52(4):1071-8. PubMed ID: 17196227
    [Abstract] [Full Text] [Related]

  • 17. Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats.
    Auclair AL, Galinier A, Besnard J, Newman-Tancredi A, Depoortère R.
    Psychopharmacology (Berl); 2007 Jul 23; 193(1):45-54. PubMed ID: 17393144
    [Abstract] [Full Text] [Related]

  • 18. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice.
    Dulawa SC, Hen R, Scearce-Levie K, Geyer MA.
    Psychopharmacology (Berl); 1997 Jul 23; 132(2):125-34. PubMed ID: 9266609
    [Abstract] [Full Text] [Related]

  • 19. Prepulse inhibition in fawn-hooded rats: increased sensitivity to 5-HT1A receptor stimulation.
    Martin S, Lawrence AJ, van den Buuse M.
    Eur Neuropsychopharmacol; 2004 Oct 23; 14(5):373-9. PubMed ID: 15336298
    [Abstract] [Full Text] [Related]

  • 20. Does genetic BDNF deficiency in rats interact with neurotransmitter control of prepulse inhibition? Implications for schizophrenia.
    van den Buuse M, Biel D, Radscheit K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr 03; 75():192-198. PubMed ID: 28192174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.